Clinical Trials Browser

Solid Tumors

Solid Tumors

Solid Tumor, Adult

Solid Tumor, Adult

Malignant Female Reproductive System Neoplasm

Advanced Solid Tumor

Advanced or Metastatic Solid Tumors

Metastatic Solid Tumors

Solid Tumors

Solid Tumours

Advanced Solid Tumor Malignancies

Solid Tumor Malignancies

Advanced Solid Tumor Cancer

Mesothelioma, Malignant

HER-2 Positive Advanced Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Hematopoietic and Lymphatic System Neoplasm

Advanced Solid Tumors

Solid Tumors

Solid Tumor Malignancies

Advanced-stage Solid Tumors

Advanced Solid Tumor

Advanced Solid Tumor

TP53 Y220C Mutation

Advanced or Metastatic Solid Tumors

Solid Tumors

Advanced Solid Tumour

Solid Tumors Harboring MET Amplification

Solid Tumors, Adult

Advanced Malignant Solid Tumors

Advanced/Metastatic Solid Tumors

Advanced Solid Tumour

Solid Tumors

Locally Advanced Solid Tumors

Advanced Solid Tumors That Are MTAP Deficient

Advanced Cancer

Advanced Solid Tumours

Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Solid Tumor, Adult

Resectable MMR-deficient Solid Tumors

Advanced Solid Tumors

Clinical Trials

aCCeleR8-001

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

ImmuCCo

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

Bi-MAPS

A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

SNV4818 in Participants With Advanced Solid Tumors

A Study of HS-20110 in Participants With Advanced Solid Tumors

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

Study in Advanced Solid Tumor Patients

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

LuMIERE

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

DAPA-ARMOR

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

PRIMROSE

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Okgyn1

NEOASIS

A Study of BG-C477 in Participants With Advanced Solid Tumors

Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors